XML 43 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional  Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020   94,483,136      
Beginning balance at Dec. 31, 2020 $ 2,746,649 $ 931 $ 2,354,871 $ 330,555 $ 60,292
Increase (Decrease) in Stockholders' Equity          
Net income 339,889     339,889  
Other comprehensive (loss) income (68,154)       (68,154)
Repurchase and retirement of common stock (in shares)   (479,944)      
Repurchase and retirement of common stock (18,067) $ (5) (11,942) (6,120)  
Cash dividends declared (121,887)     (121,887)  
Dividend equivalents declared 0   487 (487)  
Share-based compensation expense 13,264   13,264    
Issuance of restricted stock, net (in shares)   472,431      
Issuance of restricted stock, net 0 $ 3 (3)    
Restricted stock surrendered and canceled (in shares)   (166,287)      
Restricted stock surrendered and canceled (6,384)   (6,384)    
Exercise of stock options, net (in shares)   80,207      
Exercise of stock options, net 1,001 $ 0 1,001    
Ending balance (in shares) at Dec. 31, 2021   94,389,543      
Ending balance at Dec. 31, 2021 2,886,311 $ 929 2,351,294 541,950 (7,862)
Increase (Decrease) in Stockholders' Equity          
Net income 283,743     283,743  
Other comprehensive (loss) income (257,385)       (257,385)
Cash dividends declared (125,160)     (125,160)  
Dividend equivalents declared 0   493 (493)  
Share-based compensation expense 18,925   18,925    
Issuance of restricted stock, net (in shares)   827,761      
Issuance of restricted stock, net 0 $ 4 (4)    
Restricted stock surrendered and canceled (in shares)   (248,870)      
Restricted stock surrendered and canceled (8,918)   (8,918)    
Exercise of stock options, net (in shares)   53,326      
Exercise of stock options, net $ 873 $ 0 873    
Ending balance (in shares) at Dec. 31, 2022 95,021,760 95,021,760      
Ending balance at Dec. 31, 2022 $ 2,798,389 $ 933 2,362,663 700,040 (265,247)
Increase (Decrease) in Stockholders' Equity          
Net income 30,852     30,852  
Other comprehensive (loss) income 165,622       165,622
Cash dividends declared (126,265)     (126,265)  
Dividend equivalents declared 0   490 (490)  
Share-based compensation expense 19,390   19,390    
Issuance of restricted stock, net (in shares)   1,085,234      
Issuance of restricted stock, net 0 $ 4 (4)    
Restricted stock surrendered and canceled (in shares)   (308,818)      
Restricted stock surrendered and canceled (6,373)   (6,373)    
Exercise of stock options, net (in shares)   61,916      
Exercise of stock options, net $ 966 $ 1 965    
Ending balance (in shares) at Dec. 31, 2023 95,860,092 95,860,092      
Ending balance at Dec. 31, 2023 $ 2,882,581 $ 938 $ 2,377,131 $ 604,137 $ (99,625)